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Summary.-Immunofluorescence studies of sera from mice with induced enhance-
ment of tumour growth demonstrated that these sera contained factors ("interfering
factors") which in an apparently competitive manner interfered with the subsequent
binding of specific antibodies to antigenic sites on the tumour-cell membrane. The
factors were tumour-specific but lacked some of the immunoglobulin determinants.
They could not be detected by polyvalent FITC-antimouse y-globulin. Interfering
factors did not seem to be related to IgA or IgE. They were demonstrable in sera
from tumour -free animals without growing tumours, thus differingfrom the tumour-
specific "blocking factors".
THE MECHANISM of immunological tum-
our enhancement has frequently been
discussed (Kaliss, 1970; Snell, 1970;
Winn, 1970). Several mechanisms which
contribute to the escape of antigenic
tumours from immunological control have
been described. Specific blocking factors
which prevent immune lymphocytes from
killing tumour cells represent one of the
more extensively studied immunologically
specific escape mechanisms (Hellstrom
et al., 1977, Baldwin & Price, 1976).
Antibodies (Hellstrom et al., 1977) antigen
-antibody complexes (Sjogren et al.,
1971; Baldwin et al., 1972) and tumour
antigens (Currie & Basham, 1972; Thomp-
son et al., 1973) may turn off the immune
responsetotumourantigenin aspecificway.
In a previous publication, Laursen
and Laursen (1978) have described en-
hanced growth of tumour grafts after
two prior intracaecal inoculations of
either frozen-thawed C3H mouse ascites
tumour cells or live C3H mammary
tumour cells. The induced enhancement
was transferable to untreated animals by
serum and by spleen cells.
In the present work the tumour-
specific activity of sera from intracaecally
immunized C3H mice was studied by the
indirect membrane immunofluorescence
technique. It was found that sera obtained
from immunized animals, which on subse-
quent s.c. or i.p. tumour challenge showed
either protection or enhancement, reacted
antagonistically.
MATERIALS AND METHODS
Eight- to 10-week-old inbred mice of the
C3H Fib strain were used for this wvork. Most
of the animals were kept under conventional
conditions and maintained on a standard
pellet diet and water ad libitum. The animals
for the experiments in Tables IV and V,
however, were raised under specific-patho-
gen-free (SPF) conditions and kept under
minimal disease conditions during the experi-
ment.
The C3H-LI/a ascites tumour was estab-
lished from cultures of C3H mouse lung
fibroblasts which had undergone spontaneous
malignant transformation during propaga-
tion in vitro (Kieler et al., 1972).
The mammary carcinoma arose spon-
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taneously in a C3H Fib miiouse. It, wras passed
serially by the s.e. route. The adenocareino-
inatous nature of the tumour was confirmed
1wr histological examination.
The STABAL-2 tumour was induced in a
female ST/a mouse by dimethylbenzain-
thracene anid passed serially by i.p. injection
as an ascites tumour (Monti-Bragadin &
Ulrich, 1972).
The preparation of single-cell suspension
fIrom t,he mammnary tumour and the proce-
dure for immunization by the intracaecal
(i.c.) route have been described elsewhere
(Laursen & Laursen, 1978).
Specific antibodies to the tumour-cell
milembrane were demonstrated by the in-
direct immunofluorescence technique (Mo1er,
1964) using live cells as targets. St,aining
was carried out with fluorescein-conjugatied
polyvalent antimouse y-globulin (FITC-glo-
bulin) produced in goats and purchased from
Hyland or Nordic.
The various t,est sera were obtained from
adult C3H mice immunized at a one-week
interval by s.c. or i.c. injection of live cells
or cells devitalized by 5 cycles of freezing and
thawing.
Two weeks after the last injection, blood
samples were withdrawn from the retro-
orbital sinus. After clotting at room tempera-
ture the serum was harvested by centrifuga-
tion and stored at -70°C.
The target cells were washed in phosphate-
buffered saline (PBS), incubated for 20 min in
the serum to be tested at room temperature,
washed x 3 in PBS and re-incubated for
20 min in FITC-globulin diluted 1:10. After
3 final washes, slides wrere mounted and
examined under the fluorescence microscope.
By double incubation in test sera and
positive-control sera the target cells were
washed twice in PBS between the two
incubations.
Positive-control serum was obtained by
3-5 s.c. injections of live tumour cells into
C3H mice. This serumn contained specific
antibodies to the tumour-cell membrane
detectable by the fluorescence test.
Speckled staining of cell surface with soimie
aggregation of FITC-globulin, which ap-
peared as a fluorescent ring when the equator
of the cell was in focus, was considered as a
positive staining reaction. Homogeneous
staining is due to reaction w-ith dead-cell
cytoplasm: these cells o-ere excluded from
counts.
The fluotescent index wNas calculated as
(a-b)/a, where a = the percentage of fluores-
cent-negative cells treated with normal
control serum, and b = the percentage of
fluorescent-negative cells treated w,Nith the
seirum to be tested (Klein & Klein, 1964).
In order to ascertain the immune status
of the serum donors a secondary challeinge
with live tumour cells NN-as given by i.p.
injection. The percentage of takes and the
survival time N-ere recorded.
The relative contents of IgA, IgG anid 1gM
in sera from mice raised under conventional
and SPF conditions respectively Nere com-
pared by rocket immunoelectrophoresis as
described by Axelsen et al. (1973).
Briefly, 1-mm-thick agarose gel containingy
75 ,ul antimouse immunoglobulins per 10 rnl
gel was used. The specific antimouse immuno-
globulins were produced in goats and ob-
tained from Meloy Laboratory, Virginia,
U.S.A. Eleetrophoresis was carried out at
8 V/cm in the gel for 2 h.
RESULTS
Table I shows the resuilts of immunrno-
fluorescence studies with C3H-L1/a cells
as target cells and sera derived firom
animals immunized by the s.c. or i.c.
injection of live or frozen-thawed C(3H-
LI/a cells. Each animal received 2 weekly
injections of 107 cells. Two weeks later
samples of 100 dul of blood were with-
drawn from the retro-orbital sinus. Im-
mediately afterwards the donors were
challenged i.p. with 107 C3H--LI/a cells.
The table shows that specific antibodies
were detectable after s.c. immunization,
both when live cells and when frozen-
thawed cells were used. In contrast,
i.c. immunization induced detectable anti-
bodies only in mice immunized with
live cells, while mice immunized in the
same way with frozen-thawed ascites
cells had no detectable antibodies. In the
first 3 groups, protection against the
challenging graft was seen, whilst the
opposite immune reaction, enhanced ttu-
mour growth, was observed in the last
group, which was preimmunized by the
i.c. injection of frozen-thawed material.
The Figure shows in Curve A the
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TABLE I.-Indirect immunofluorescence and transplantation studies of the immune
response of C3H mice to two s.c. or intracaecal (i.c.) injections of live andfrozen-
thawed (fr-th) C3H-LI/a cells
Immunization
route/material
s.c./live cells
s.c./fr-th cells
i.c./live cells
i.c./fr-th cells
Non-immunized
Fluorescent index
serum dilution
1:2 1:8 1:32
0-96 1 00 0-92
0-88 0-92 0-65
0 95 0-86 0-62
0-12 0-18 0-15
Blood samples withdrawn 2 weeks after the second immunization dose and pooled. Immediately after-
wards the mice were challenged with 107 C3H-LI/a tumour cells i.p. Survivors observed for 3 months.
* According to Mann-Whitney's rank-sum test, this group showed enhanced growth of the i.p. graft over
the non-immunized controls.
means of the fluorescent indices obtained
by 2 investigations of 3 different enhanc-
ing sera. The fluorescence tests were
carried out on different days, and on
each occasion all 3 sera were investigated.
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FIG.-Indirect immunofluorescence studies
of the interfering effect ofenhancing serum
on the reaction of C3H-L 1/a cells with a
positive isoantiserum. A: Target cells
incubated with enhancing serum, washed
and stained with FITC-gammaglobulin.
B: Target cells incubated with enhancing
serum, washed and subsequently incubated
with a positive-control serum before
staining with FITC-globulin. Dotted line:
target cells incubated in the positive-
control serum diluted 1:4, washed and
stained with FITC-globulin. Donors of
enhancing sera were twice immunized with
frozen-thawed C3H-LI/a cells injected i.c.
Two weeks later blood samples were taken
and the mice grafted with the tumour cells
i.p. This i.p. graft showed enhanced growth
when compared with grafts in non-im-
munized animals. The positive control
serum was pooled from 20 C3H mice im-
munized by 4 weekly s.c. injections of 107
C3H-L 1/a cells. Each point is the mean of
6 determinations. Staples indicate s.e.
Donors of enhancing sera were twice
immunized by i.c. injection of frozen-
thawed C3H-L1/a cells. When target cells
were incubated in serum diluted 1:2,
fluorescent indices with a mean of 0 20
were observed, whilst a mean of 0 53 was
obtained at a serum dilution of 1:8.
Decreasing values were found at higher
dilutions of serum.
Curve B represents the mean of the
fluorescent indices which were seen after
double incubation, first in serial dilutions
of enhancing serum as in A, and subse-
quently in a positive-control serum (dilu-
tion 1:4) pooled from 20 mice immunized
by the s.c. route. As can be seen, pre-
treatment with enhancing serum at a
dilution of 1: 2 produced a decrease of the
fluorescent index from a control level of
0-95 to 0-38. After pretreatment with
higher dilutions of enhancing serum, in-
creasing indices were recorded. At a
dilution of 1: 32 the fluorescent index had
risen to the control level.
Table II shows some other results of
immunofluorescence investigations with
target cells double-incubated as described
above.
With sera obtained by s.c. immuniza-
tion with C3H-L1/a ascites cells or mam-
mary tumour cells (MTC), the respective
target cells revealed a positive fluores-
cence. I.c. immunization with either
frozen-thawed ascites cells or live MTC
yielded only very weak antisera. Preincu-
bation with these weak antisera, and
No. of
takes/total
0/14
3/14
2/12
12/12
14/15
Mean
survival
(days)
26
25
17±2-1*
24±1 7
InnO r-
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TABLE II.-Indirect immunofluorescence studies of the interfering effect of enhanc-
ing sera on the reaction between C3H-Ll/a and C3H mammary tumour cells
(MTC) and their respective iso-antisera
Serum dilution of 1st incubation
First
Target cells incubation
C3H-L1/a Serum 1
Serum 2
Serum 2
Serum 4
MTC Serum 3
Serum 4
Serum 4
Serum 2
Second*
incubation
PBS
PBS
Serum 1
Serum 1
PBS
PBS
Serum 3
Serum 3
1:2 1:8 1:32
A
Fluorescent index
(mean of 2 tests)
0-96 0-98 0-93
0-10 0-27 0-18
0-22 0-55 0-80
1-00 0-93 0*95
0-89 0-94 0-92
0-25 0-33 0-15
0-22 0-35 0-65
0-97 0-87 0-91
* For the second incubation the positive serum was used at a dilution of 1:4.
Serum 1 obtained by s.c. immunization with live C3H-L1/a cells.
Serum 2 obtained by i.c. immunization with frozen-thawed C3H-L1/a cells.
Serum 3 obtained by s.c. immunization with MTC.
Serum 4 obtained by i.c. immunization with MTC.
All sera pooled from 8-10 mice immunized twice with a one-week interval. Sera 2 and 4 were obtained
from donors which on subsequent challenge showed enhanced tumour growth. The target cells were washed
in PBS between the 2 incubations.
TABLE III.-Indirect immunofluorescence studies of the specific absorption of the
interfering activity ofenhancing sera
Serum
absorbed with
Nil
C3H-L1 ascites
tumour cells
STABAL-2 ascites
tumour cells
Type of
test
A
B
A
B
A
B
Fluorescent index
Serum dilution
A
1:2 1:8 1:32
0-15 0-40 0 33
0-28 0.55 0-82
0*62 0*55 0*32
0-85 0-92 0-88
0-28 0-36 0-25
0 30 0-65 0-90
Enhancing serum obtained by i.c. immunization twice with a one-week interval with frozen-thawed
C3H-L1 ascites cells was absorbed with 2 x 107 of cells as indicated.
Test A: the C3H-L1 ascites cells were incubated in the absorbed serum, washed andstainedwith FITC-y-
globulin.
Test B: the target cells were subjected to a second incubation in a positive-control serum before staining
with the FITC-globulin.
washing twice in PBS before incubation
with the positive sera, considerably and
specifically reduced the reaction of target
cells with the latter. The enhancing sera
raised against C3H-LI/a cells and MTC
did not cross-react.
Table III shows the results of an
immunofluorescence test with enhancing
serum, which before testing was absorbed
with C3H-L1/a or STABAL-2 ascites
tumour cells. As can be seen, absorption
with C3H-L1/a specifically increased the
immunofluorescent index after single incu-
bation in enhancing serum, and double
incubation in enhancing serum and posi-
tive control serum. Absorption with STA-
BAL-2 had no such effect.
All experiments reported above were
carried out with conventionally housed
C3H mice. However, different results
were obtained with mice raised under
specific-pathogen-free (SPF) conditions.
These mice are of the same strain as our
conventionally housed C3H mice.
Table IV shows, in contrast to previous
experiments, that attempts to induce
enhanced tumour growth by inoculating
107 frozen-thawed ascites cells twice into
the caecal lumen ofC3H mice raised under
SPF conditions were unsuccessful. Twenty
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TABLE IV. Innmunological response of C3H mice raised under SPF conditions to i.c.-
inoculated viable and non-viable C3H-L 1/a tumour cells
Fluiorescent in(dex3
Serum (lilutions
State of i.e.-iijectedl
C'dlls1
Live
Frozen-thawed x 5
Controls
No. of
takes/total2
1/20
0/20
19/20
1:2
(a) 0-78
(a) 0 - 74
(b) 0-95
1:4 1:8 1:16 1:32
0-88 0-74 0*63 0-36
0-71 0-40 0-27 0-11
0-95 0.98 0-9( 0-92
I Two weekly i.e. injections of 107 C3H-Ll/a cells.
2 After secon(lary i.p. challenge with 107 C3H-LI/a cells.
3 Indiiect immunofluorescence test, (a) single incubation in (lonor seruim as in(licate(d before stainiing with
FITC-y-globtilin ancd (b) (louble incubation, first in serum from animals immtunize(d i.c. with frozein-thawed1
cells, and(l subsequently, after washing, in positive-control serum.
immtlnizled mice survived the challenging
graft,, which was deadly for non-im-
munized controls.
The grouLp immunized i.e. with frozen-
thawed cells showed a lower immuno-
fluorescent index at dilutions above 1:4
than the group immunized with live cells.
Sera from mice immunized i.c. with frozen-
thawed cells did not, have any interfering
capacity in this experiment for the reaction
with positive-control serum.
TABLE V. Relative content of
immunoglobu.lins in C3H mice
raised under SPF conditions
Relative values*
lg class
IgA
Igil
IgGi
IgG2
AlIean
127
115
51
:32
Range
100-148
65-135
42-63
21-42
* Percerntage of the correspon(ling concentration
imu conventionally houise(d mice.
4 ser-a pooled( from 8-10 C31 mice were compare(d
twice by rocket immtunoelectrophoresis to (lifferent
sera from conventionally housed C:1 mice. Each
measurement carried out at 4 (liluitions of sera.
The relative content of immunoglobul-
ins in sera from our SPF C3H mice is
shown in Table V. The concentrations of
IgA and IgM were about the same in
SPF mice as in conventionally housed
C3H mice. The Ig( was found to be low
in the SPF mice.
In the last immunofluorescence studv
to be reported here C3H-L1 /a cells had
been incubated in either untreated en-
hancing serum or in the same serum
heated. Incubation ofthe sertim for 30 min
at 56 C did not destroy the interfering
capacity, which was measured as des-
cribed above. By single incubation in
untreated or heated enhancing serum
diluted 1: 2 before staining with FITC(-
globulin, the fluorescent indices were
0 15 and 0d12 respectively. WVhen the
target cells were further incubated in a
positive-control serum before staining,
fluorescent indices of 0 38 and 0 32 were
obtained. Cells treated with positive-
control serum had a fluorescent index of
0 90.
DISCUSSION
The possibility of enhancing tumour
growth by a prior immunization via the
intestinal route has previously been re-
ported by Laursen & Laursen (1978).
Several studies suggest that enhance-
ment could be mediated by specific
antibodies (Kaliss, 1958; Winn, 1970;
Snell, 1970; Takasugi & Hildemann,
1969; Ran & Witz, 1972).
In the present, immunofluorescence
studies, specific antibodies could not be
demonstrated in sera from mice with
enhanced tumour growth, unless these
sera were diluted or subjected to partial
specific absorption.
However, the data presented in the
Figure and Tables II and III suggest
the presence in enhancing serum of
factors able to interfere with the subse-
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quent binding of tumour-specific anti-
bodies in the positive-control serum
to the membrane of the appropriate
tumour cells. It is conceivable that these
factors had covered the antigenic sites
on the tumour-cell membrane. They were
specifically absorbed by the immunizing
tumour cells, but they lacked determin-
ants detectable by polyvalent FITC-
conjugated goat anti-mouise gammaglobu-
lin.
C3H-L1/a cells treated with a 1:4
dilution of the positive-control serum
after preincubation with enhancing serum
at a dilution of 1:2 showed a somewhat
higher fluorescent index than cells treated
with enhancing serum alone (Figure).
This indicates, either that not all anti-
genic sites were covered by factors in the
enhancing serum, or that the interfering
factors can be replaced by competing
specific antibodies.
The interfering phenomenon has only
been detectable when using serum from
animals in which intestinal immunization
was followed by enhanced growth of the
challenging tumour. No interfering factors
were detectable in serum from experi-
ments in which inhibition of tumour
growth followed the intestinal immuniza-
tion.
These observations indicate that en-
hancing serum contains factors with
specificity and affinity for tumour-associa-
ted antigens, but that compared with the
positive-control serum these factors lack
certain immunoglobulin determinants.
It has been shown that blocking sera
facilitated tumour growth (Takasugi &
Klein, 1971; Bansal et al., 1972) and
prevented immune lymphocytes from kil-
ling tumour cells in cytotoxicity assays.
But blocking factors were only detectable
in sera from individuals bearing tumours;
they disappeared rapidly after tumour
excision (Sjogren and Bansal, 1971; Bald-
win et al., 1973).
The factors presented in this paper
could only be demonstrated in sera from
animals in which intestinal immunization
was followed by enhanced tumour growth.
When bled, the animals were without
growing tumours. The factors were detect-
able even 6 weeks after inoculation of
dead cells into the intestinal lumen
(unpublished data) and interfered with
the determination of specific antibodies
in vitro.
Crabbe et al. (1969) provided evidence
of a local intestinal immunological res-
ponse after ingestion of horse ferritin to
germ-free C3H mice. More than 80OO
of the immunocytes investigated in the
intestinal mucosa produced IgA. Dolozel
& Bienenstock (1971) have published
similar results but in conventional ham-
sters.
Such findings directed attention to-
wards IgA in the present study. How-
ever, in C3H mice raised under SPF
conditions, neither enhanced tumour
growth nor interfering factors could be
induced by the i.c. route as in conven-
tionally housed mice of the same strain.
But the serum IgA level was the same in
mice raised under SPF or under con-
ventional conditions. Since 80%/ of the
serum IgA should be provided by the
IgA immunocytes of the intestinal mucosa
(Vaerman et al., 1973; Bazin et al., 1970),
equal serum IgA levels would indicate
that the numbers of IgA-producing im-
munocytes in the intestinal wall of SPF
mice are comparable to the numbers in
conventional C3H mice. Because inter-
fering factors were undetectable in serum
from SPF mice, however, IgA is unlikely
to have acted in such a manner.
Mota (1967) reported that incubation
for 30 min at 56 C destroyed the passive
cutaneous anaphylactic activity of mouse
IgE. Such heating of enhancing serum
did not decrease its interfering capacity.
Elucidation of the nature of the inter-
fering factors in enhancing serum requires
further investigation. Future experiments
should clarify whether these factors pro-
vide a mechanism whereby the anti-
genic tumours can escape immunological
destruction. Such studies might provide
information of basic importance to the
understanding of immune reactions.
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